Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest press releases The press releases are intended for media and financial analysts Press release 16 Oct 2026 UCB announces U.S. FDA approval for ZILBRYSQ[®] (zilucoplan) autoinjector self-administration for... Read More Press release 30 Sep 2026 UCB announces new data at EADV 2026 supporting earlier use of BIMZELX[®] (bimekizumab) for treating... Read More Press release 30 Sep 2026 UCB announces new data at EADV 2026 supporting earlier use of BIMZELX[®] (bimekizumab) for treating... Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Press release 16 Oct 2026 UCB announces U.S. FDA approval for ZILBRYSQ[®] (zilucoplan) autoinjector self-administration for... Read More
Press release 30 Sep 2026 UCB announces new data at EADV 2026 supporting earlier use of BIMZELX[®] (bimekizumab) for treating... Read More
Press release 30 Sep 2026 UCB announces new data at EADV 2026 supporting earlier use of BIMZELX[®] (bimekizumab) for treating... Read More